Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms.

Abstract excerpt

Whole exome next generation sequencing systematically applied as a discovery tool in myelodysplastic syndromes (MDS) has led to the identification of a large number of novel mutations. Despite hundreds of patients studied, mutational saturation has not been reached and it is expected that new driver mutations will be discovered in this very heterogeneous condition. Serial samples and deep sequencing of the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to High-Throughput Nucleotide Sequencing
• Share to Mutation